SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|Date of Report (Date of Earliest Event Reported):||September 28, 2010|
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
|of incorporation)||File Number)||Identification No.)|
|2300 Corporate Park Drive, Herndon, Virginia||20171|
(Address of principal executive offices)
|Registrants telephone number, including area code:||(703) 483-7000|
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Dr. Craig R. Barrett, age 71, was appointed to the Board of Directors (the "Board") of K12 Inc. (the "Company"), effective September 28, 2010. Dr. Barrett was previously Chief Executive Officer and Chairman of Intel Corporation. Dr. Barrett will serve as a Director of the Company until the next annual meeting of shareholders of the Company and until his successor is elected and qualified or until his death, retirement, resignation or removal. In addition to his appointment to the Board, Dr. Barrett was named to serve on the Company’s Nominating and Corporate Governance Committee. All similar non-employee Directors of the Company receive an annual restricted stock award equivalent to $60,000, a cash retainer of $40,000 per year for service as a Director, and meeting fees. There are no arrangements or understandings between Dr. Barrett and any other person pursuant to which Dr. Barrett was appointed a Director of the Company.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|September 29, 2010||By:||
/s/ Howard D. Polsky
|Name: Howard D. Polsky|
|Title: General Counsel and Secretary|